THE RESULTS OF TREATING MELASMA AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2023-2024

Thị Bảy Qúach, Văn Bá Huỳnh, Thị Xuân Tâm Huỳnh

Main Article Content

Abstract

Background: Treatment of melasma often uses a combination of laser, depigmentation cosmetics, and oral medications. Objective: Evaluating patient treatment results of melasma treatment  at Can Tho University of Medicine and pharmacy hospital in 2023-2024. Materials and methods: Cross-sectional descriptive study on 85 melasma patients treated at Can Tho University of Medicine and Pharmacy Hospital from July 2023 to April 2024. Results: 76.5% were satisfied with the results of the medical examination; 69.4% were satisfied with the treatment time. Melasma treatment with Q-Switched Nd: YAG laser method combined with applying Tri-White Serum was safe. MASI score decreased from 7.5±4.7 to 4.9±3.5 after treatment (p <0.001). The rate of melasma improvement was 69.4%. Conclusion: Melasma treatment using Q-Switched Nd: YAG laser method combined with applying Tri-White Serum is safe, effective, and receives satisfaction/trust from patients.

Article Details

References

Lê Minh Hoài (2020), Nghiên cứu đặc điểm lâm sàng và đánh giá kết quả điều trị rám má bằng laser Q-Switched Nd: YAG kết hợp bôi Tri-white Serum tại Bệnh viện Trường Đại học Y dược Cần Thơ năm 2019-2020 Luận văn bác sĩ chuyên khoa II, Trường Đại học Y dược Cần Thơ.
2. Nguyễn Văn Thường (2017), “Bệnh rám má”, Bệnh học da liễu, nhà xuất bản Y học, Hà Nội, tr.143-147.
3. Cao Thị Thúy Vân (2023), “Nghiên cứu đặc điểm lâm sàng, một số yếu tố liên quan và đánh giá kết quả điều trị tàn nhang bằng laser Q-Swichsed Nd:YAG kết hợp bôi Tri-white Serum tại Bệnh viện Trường Đại học Y dược Cần Thơ năm 2021-2022”, Tạp chí Y dược học Cần Thơ, Số 56/2023, tr. 121-129.
4. Ali K.I., Ghias A., Saeed W., Chaudhry Z.S., et al. (2023), “Therapeutic efficacy and safety of Fractional Carbon dioxide Laser versus Q-Switched Nd:YAG 1064nm Laser in the treatment of Melasma: A comparative interventional study Introduction”, Journal of Pakistan Association of Dermatologists, 33(1), pp. 149-156.
5. Babbush K.M., Babbush R.A., Khachemoune A. (2020), “The Therapeutic Use of Antioxidants for Melasma”, Journal of Drugs in Dermatology, 19(8), pp. 788-792.
6. Beyzaee A.M., Patil A., Goldust M., et al. (2021), “Comparative Efficacy of Fractional CO2 Laser and Q-Switched Nd:YAG Laser in Combination Therapy with Tranexamic Acid in Refractory Melasma: Results of a Prospective Clinical Trial”, Cosmetics, 8, pp. 37-43.
7. Chandorkar N., Tambe S., Amin P. (2021), “Alpha Arbutin as a Skin Lightening Agent: A Review”, International Journal of Pharmaceutical Research, 13(2), pp. 3502-10.
8. Hay R.A., Sayed K.S., Mohammed F.N. (2020), “Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser”, Dermatologic Therapy, Published online.
9. Lee Y.S., Lee Y.J., Lee J.M., et al., (2022), “The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review”, Medicina, 58, pp. 936-969.
10. Micek I., Pawlaczyk M., Kroma A., et al., (2021), “Treatment of melasma with a low‐fluence 1064 nm Q‐switched Nd:YAG laser: Laser toning in Caucasian women”, Lasers Surg Med, pp. 1-8.